Rofecoxib and nimesulide differ in speed and magnitude of their antinociceptive effect: A randomized double-blind crossover neurophysiological study in normal subjects

Roberto Casale, Pietro Balbi, Giuseppe Frazzitta, Cira Fundarò, Francesco Ceccherelli, Gian D. Pinna

Research output: Contribution to journalArticle

Abstract

NSAIDs have an important central antinociceptive activity, parallel and concomitant with their peripheral anti-inflammatory effects. The nociceptive flexion reflex is an experimental model for neurophysiological studies of pain, providing a sensitive evaluation of the nociceptive threshold during various pharmacological treatments in humans. In this research, the analgesic, antinociceptive effects of rofecoxib and nimesulide were compared in a group of normal subjects, using the inhibition of the nociceptive flexion reflex threshold as marker of analgesic activity. Twelve normal male subjects (37.2±8.05 years old) were enrolled in a double-blind, three-treatment, three-period crossover design, comparing 50 mg rofecoxib and 100 mg nimesulide vs. placebo. To prevent carryover effects between treatments, a 72-hour wash-out interval was allowed between drug administrations. Nociceptive flexion reflex threshold from the caput brevis of biceps femoris caput brevis elicited by sural nerve electrical stimulation was studied before drug administration and during a 60 min observation. Nociceptive flexion reflex threshold, expressed in mAmp needed to elicit the response, was recorded every 5 min for the first 30 min and then every 10 min. Nociceptive flexion reflex rate of changes in mA/min was also calculated to define the speed of inhibition during the first 5 min and 10 min after drug administration. Rofecoxib has a better inhibitory effect on the nociceptive flexion reflex than does nimesulide with faster onset of action, a maximal inhibitory effect between 20 min and 30 min. Both drugs provided durable inhibition throughout the 60 min of recording, although nociceptive flexion reflex inhibition brought about by rofecoxib was on average 33% higher than that obtained after nimesulide.

Original languageEnglish
Pages (from-to)253-260
Number of pages8
JournalPain Clinic
Volume16
Issue number3
DOIs
Publication statusPublished - 2004

Fingerprint

nimesulide
Cross-Over Studies
Reflex
Pharmaceutical Preparations
Analgesics
Sural Nerve
Non-Steroidal Anti-Inflammatory Agents
rofecoxib
Electric Stimulation
Anti-Inflammatory Agents
Theoretical Models
Therapeutics
Placebos
Observation

Keywords

  • Nimesulide
  • Nociceptive flexion reflex
  • Rofecoxib

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Rofecoxib and nimesulide differ in speed and magnitude of their antinociceptive effect : A randomized double-blind crossover neurophysiological study in normal subjects. / Casale, Roberto; Balbi, Pietro; Frazzitta, Giuseppe; Fundarò, Cira; Ceccherelli, Francesco; Pinna, Gian D.

In: Pain Clinic, Vol. 16, No. 3, 2004, p. 253-260.

Research output: Contribution to journalArticle

@article{25011e39502f4942aff2c45728d4f07f,
title = "Rofecoxib and nimesulide differ in speed and magnitude of their antinociceptive effect: A randomized double-blind crossover neurophysiological study in normal subjects",
abstract = "NSAIDs have an important central antinociceptive activity, parallel and concomitant with their peripheral anti-inflammatory effects. The nociceptive flexion reflex is an experimental model for neurophysiological studies of pain, providing a sensitive evaluation of the nociceptive threshold during various pharmacological treatments in humans. In this research, the analgesic, antinociceptive effects of rofecoxib and nimesulide were compared in a group of normal subjects, using the inhibition of the nociceptive flexion reflex threshold as marker of analgesic activity. Twelve normal male subjects (37.2±8.05 years old) were enrolled in a double-blind, three-treatment, three-period crossover design, comparing 50 mg rofecoxib and 100 mg nimesulide vs. placebo. To prevent carryover effects between treatments, a 72-hour wash-out interval was allowed between drug administrations. Nociceptive flexion reflex threshold from the caput brevis of biceps femoris caput brevis elicited by sural nerve electrical stimulation was studied before drug administration and during a 60 min observation. Nociceptive flexion reflex threshold, expressed in mAmp needed to elicit the response, was recorded every 5 min for the first 30 min and then every 10 min. Nociceptive flexion reflex rate of changes in mA/min was also calculated to define the speed of inhibition during the first 5 min and 10 min after drug administration. Rofecoxib has a better inhibitory effect on the nociceptive flexion reflex than does nimesulide with faster onset of action, a maximal inhibitory effect between 20 min and 30 min. Both drugs provided durable inhibition throughout the 60 min of recording, although nociceptive flexion reflex inhibition brought about by rofecoxib was on average 33{\%} higher than that obtained after nimesulide.",
keywords = "Nimesulide, Nociceptive flexion reflex, Rofecoxib",
author = "Roberto Casale and Pietro Balbi and Giuseppe Frazzitta and Cira Fundar{\`o} and Francesco Ceccherelli and Pinna, {Gian D.}",
year = "2004",
doi = "10.1163/1568569041798362",
language = "English",
volume = "16",
pages = "253--260",
journal = "Pain Clinic",
issn = "0169-1112",
publisher = "Maney Publishing",
number = "3",

}

TY - JOUR

T1 - Rofecoxib and nimesulide differ in speed and magnitude of their antinociceptive effect

T2 - A randomized double-blind crossover neurophysiological study in normal subjects

AU - Casale, Roberto

AU - Balbi, Pietro

AU - Frazzitta, Giuseppe

AU - Fundarò, Cira

AU - Ceccherelli, Francesco

AU - Pinna, Gian D.

PY - 2004

Y1 - 2004

N2 - NSAIDs have an important central antinociceptive activity, parallel and concomitant with their peripheral anti-inflammatory effects. The nociceptive flexion reflex is an experimental model for neurophysiological studies of pain, providing a sensitive evaluation of the nociceptive threshold during various pharmacological treatments in humans. In this research, the analgesic, antinociceptive effects of rofecoxib and nimesulide were compared in a group of normal subjects, using the inhibition of the nociceptive flexion reflex threshold as marker of analgesic activity. Twelve normal male subjects (37.2±8.05 years old) were enrolled in a double-blind, three-treatment, three-period crossover design, comparing 50 mg rofecoxib and 100 mg nimesulide vs. placebo. To prevent carryover effects between treatments, a 72-hour wash-out interval was allowed between drug administrations. Nociceptive flexion reflex threshold from the caput brevis of biceps femoris caput brevis elicited by sural nerve electrical stimulation was studied before drug administration and during a 60 min observation. Nociceptive flexion reflex threshold, expressed in mAmp needed to elicit the response, was recorded every 5 min for the first 30 min and then every 10 min. Nociceptive flexion reflex rate of changes in mA/min was also calculated to define the speed of inhibition during the first 5 min and 10 min after drug administration. Rofecoxib has a better inhibitory effect on the nociceptive flexion reflex than does nimesulide with faster onset of action, a maximal inhibitory effect between 20 min and 30 min. Both drugs provided durable inhibition throughout the 60 min of recording, although nociceptive flexion reflex inhibition brought about by rofecoxib was on average 33% higher than that obtained after nimesulide.

AB - NSAIDs have an important central antinociceptive activity, parallel and concomitant with their peripheral anti-inflammatory effects. The nociceptive flexion reflex is an experimental model for neurophysiological studies of pain, providing a sensitive evaluation of the nociceptive threshold during various pharmacological treatments in humans. In this research, the analgesic, antinociceptive effects of rofecoxib and nimesulide were compared in a group of normal subjects, using the inhibition of the nociceptive flexion reflex threshold as marker of analgesic activity. Twelve normal male subjects (37.2±8.05 years old) were enrolled in a double-blind, three-treatment, three-period crossover design, comparing 50 mg rofecoxib and 100 mg nimesulide vs. placebo. To prevent carryover effects between treatments, a 72-hour wash-out interval was allowed between drug administrations. Nociceptive flexion reflex threshold from the caput brevis of biceps femoris caput brevis elicited by sural nerve electrical stimulation was studied before drug administration and during a 60 min observation. Nociceptive flexion reflex threshold, expressed in mAmp needed to elicit the response, was recorded every 5 min for the first 30 min and then every 10 min. Nociceptive flexion reflex rate of changes in mA/min was also calculated to define the speed of inhibition during the first 5 min and 10 min after drug administration. Rofecoxib has a better inhibitory effect on the nociceptive flexion reflex than does nimesulide with faster onset of action, a maximal inhibitory effect between 20 min and 30 min. Both drugs provided durable inhibition throughout the 60 min of recording, although nociceptive flexion reflex inhibition brought about by rofecoxib was on average 33% higher than that obtained after nimesulide.

KW - Nimesulide

KW - Nociceptive flexion reflex

KW - Rofecoxib

UR - http://www.scopus.com/inward/record.url?scp=4744347588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744347588&partnerID=8YFLogxK

U2 - 10.1163/1568569041798362

DO - 10.1163/1568569041798362

M3 - Article

AN - SCOPUS:4744347588

VL - 16

SP - 253

EP - 260

JO - Pain Clinic

JF - Pain Clinic

SN - 0169-1112

IS - 3

ER -